BankingBusiness

United Therapeutics Corporation: Present at the 41st Annual J.P. Morgan Healthcare Conference

United Therapeutics Corporation: Present at the 41st Annual J.P. Morgan Healthcare Conference

  • United Therapeutics Corporation is a biotechnology company focused on the development 
  • Announced that Dr. Martine Rothblatt, Chairperson and Chief Executive Officer, will provide an overview
  • Update on the company’s business during a fireside chat session at the 41st annual J.P. Morgan Healthcare Conference in San Francisco
  • The session will take place on Monday, January 9, 2023, from 1:30 p.m. to 2:10 p.m., Pacific Standard Time
  • The recorded version of the session will be available approximately 24 hours after the session ends
  • The public benefit purpose is to provide a brighter future for patients through (a) the development
Previous article
JCB: Partners with NPCI to offer 40% cashback for RuPay
Next article
Vianova: Raises €6M in Series A Funding
Laura M
Laura M
Laura is a financial reporter, editor, and researcher with a particular interest in fintech innovation, capital markets, and the evolving global banking landscape.

You May Also Like

FinTech

Italy Fines Revolut €1.15M for Regulatory Violations

Revolut faces penalties due to non-compliance with Italian financial regulations.Highlights: Italy fines Revolut €1.15 million for regulatory breaches.The...
FinTech

DeFi Platform Drift Suspends Withdrawals After Crypto Hack

Drift takes precautionary measures following security breach affecting user funds.Highlights: Drift has suspended all deposits and withdrawals after...
FinTech

Cross River Bank Raises $50 Million to Accelerate Growth

The funding will enhance Cross River Bank's financial technology services.Highlights: Cross River Bank has raised $50 million in...
FinTech

Kulipa Secures $62M to Enhance Stablecoin Card Issuing Infrastructure

Funding aims to strengthen cryptocurrency card services in the growing fintech market.Highlights: Kulipa raises $62M to enhance its...